Jian Campian

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.165Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A case series of osseous metastases in patients with glioblastoma

Medicine(2024)10.1097/md.0000000000038794

Top 70%

0.165DataRank

Top 70%2 citations

Mason Webb, Jian Campian, Samantha Caron, Michael W. Ruff, Joon H. Uhm +2 more

Papers

Driven by 28 papers — median percentile 30. Top paper: “BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas”.

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

New England Journal of Medicine(2023)10.1056/nejmoa2213329

N/A

4.5DataRank · unranked

138 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Shervin Tabrizi +23 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma

Neuro-Oncology Practice(2022)10.1093/nop/npac003

N/A

1.2DataRank · unranked

36 citations

Ruth Katumba, Jingqin Luo, Himachandana Atluri, Grayson Talcott, Ashwin Govindan +12 more

A case series of osseous metastases in patients with glioblastoma

Medicine(2024)10.1097/md.0000000000038794

Top 70%

0.165DataRank

Top 70%2 citations

Mason Webb, Jian Campian, Samantha Caron, Michael W. Ruff, Joon H. Uhm +2 more

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab041

N/A

0DataRank · unranked

74 citations

Jingqin Luo, Ruth Katumba, Grayson Talcott, Joshua B. Rubin, Erik D. Herzog +2 more

Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry

JCI Insight(2021)10.1172/jci.insight.128456

N/A

0DataRank · unranked

29 citations

Arijita Jash, Olga Malkova, Diane D. Mao, Patrick DeSouza, Yunli E. Chu +9 more

Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2000

N/A

0DataRank · unranked

20 citations

Erin Twohy, Susan Geyer, Elizabeth R. Gerstner, Timothy J. Kaufmann, Michael W. Ruff +15 more

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.4304

N/A

0DataRank · unranked

72 citations

Sonya Reid, Benjamin French, Cassandra Hennessy, Clara Hwang, Na Tosha Gatson +95 more

Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.42046

N/A

0DataRank · unranked

11 citations

Tianyi Sun, David D. Chism, Narjust Duma, Julie Fu, Na Tosha Gatson +87 more

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac041

N/A

0DataRank · unranked

10 citations

S. Keith Anderson, Erin Twohy, Nicholas Butowski, Adı́lia Hormigo, David Schiff +11 more

The interim result of a phase I/II study of nivolumab with or without ipilimumab in combination with multi-fraction stereotactic radiosurgery for recurrent, high-grade, radiation-relapsed meningioma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2068

N/A

0DataRank · unranked

10 citations

Feng Gao, Joshua S. Shimony, Tanner M. Johanns, Megan Mantica, Timothy R. Gershon +6 more

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1

Neuro-Oncology(2023)10.1093/neuonc/noad033

N/A

0DataRank · unranked

35 citations

Anna F. Piotrowski, Jian Campian, Jose Diarte, Fausto J. Rodríguez, Tejus Bale +7 more

Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad061

N/A

0DataRank · unranked

18 citations

Jean M. Lacey, Lucas P. Carlstrom, William Laxen, Amanda Munoz-Casabella, Matthew D. Hoplin +12 more

Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad123

N/A

0DataRank · unranked

16 citations

Bryan J. Neth, Lauren M. Webb, Jamie J. Van Gompel, Michael J. Link, Brian A. Neff +15 more

Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomas

medRxiv(2023)10.1101/2023.03.01.23286412

N/A

0DataRank · unranked

1 citations

Jean M. Lacey, Lucas P. Carlstrom, William Laxen, Amanda Munoz-Casabella, Matthew D. Hoplin +12 more

Data from Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models

(2023)10.1158/1078-0432.c.6530976

N/A

0DataRank · unranked

0 citations

Subhajit Ghosh, Vaishali Kapoor, Ran Yan, Sukrutha Thotala, Arijita Jash +12 more

Data from Long-Acting Recombinant Human Interleukin-7, NT-I7, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models

(2023)10.1158/1078-0432.c.6530976.v1

N/A

0DataRank · unranked

0 citations

Subhajit Ghosh, Vaishali Kapoor, Ran Yan, Sukrutha Thotala, Arijita Jash +12 more

Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma

International Journal of Molecular Sciences(2024)10.3390/ijms251910570

N/A

0DataRank · unranked

19 citations

Lauren M. Webb, Anna Thomsen, Eric J. Lehrer, William G. Breen, Jian Campian +4 more

A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology

Neuro-Oncology(2024)10.1093/neuonc/noae276

N/A

0DataRank · unranked

16 citations

Michael B. Keough, Jeffrey Zuccato, Rahul Kumar, Sebastian C Schulz, Arthur E. Warrington +14 more

Phase Ib/II Study of Pamiparib Plus Radiation Therapy and/or Temozolomide in Adult Patients with Treatment-Naïve or Recurrent/Refractory Glioblastoma

Current Oncology(2025)10.3390/curroncol32100541

N/A

0DataRank · unranked

4 citations

Kent C. Shih, Pierre Giglio, Howard Colman, Patrick Y. Wen, Jian Campian +6 more

Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf117

N/A

0DataRank · unranked

3 citations

Stuart A. Grossman, Angela Shaulov Kask, Samuel Kosydar, Roy E. Strowd, Anna F. Piotrowski +12 more

Tracking Daily Variations in Rest-Wake to Guide Personalized Timing of Temozolomide for High-Grade Glioma Patients

Journal of Biological Rhythms(2025)10.1177/07487304251336826

N/A

0DataRank · unranked

2 citations

Anna R. Damato, Ruth Katumba, Grayson Talcott, Jian Campian, Omar H. Butt +5 more

A phase I window-of-opportunity study of neoadjuvant avelumab and hypofractionated radiation therapy in radiation-relapsed meningioma

medRxiv(2025)10.1101/2025.09.26.25336740

N/A

0DataRank · unranked

0 citations

Tanner M. Johanns, Jian Campian, Michael R. Chicoine, Gregory J. Zipfel, Milan G. Chheda +15 more

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Journal of the National Comprehensive Cancer Network(2020)10.6004/jnccn.2020.0052

N/A

0DataRank · unranked

570 citations

Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem +30 more

Daily locomotor activity declines with tumor growth and disease progression in glioblastoma

JCI Insight(2025)10.1172/jci.insight.194582

N/A

0DataRank · unranked

0 citations

Sofia V. Salvatore, Anna R. Damato, Ruth Katumba, Grayson Talcott, Omar H. Butt +6 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more

Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0736

N/A

0DataRank · unranked

35 citations

Richard L. Price, Xiran Liu, Joshua Yao-Yu Lin, Qingsong Yang, Peng Sun +13 more

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022

N/A

0DataRank · unranked

33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Jian Campian

Indexed papers

Top data-sharing exemplar

Papers